|Bid||1,131.50 x 0|
|Ask||1,132.50 x 0|
|Day's range||1,122.00 - 1,147.64|
|52-week range||959.20 - 1,338.50|
|Beta (5Y monthly)||0.35|
|PE ratio (TTM)||53.93|
|Earnings date||21 Feb 2023|
|Forward dividend & yield||0.32 (2.76%)|
|Ex-dividend date||30 Mar 2023|
|1y target est||13.68|
Smith & Nephew (SNN) achieves a positive response for its COBLATION-Technology-infused Intracapsular Tonsillectomy Technique, providing fast patient recovery over existing surgeries.
Smith & Nephew (SNN) introduces QUADTRAC System and broadens ULTRABUTTON Adjustable Fixation Devices portfolio for ACL reconstruction.
Most readers would already know that Smith & Nephew's (LON:SN.) stock increased by 9.9% over the past three months...